Loading clinical trials...
Loading clinical trials...
Head-to-Head Comparison of Thymoglobulin vs. Campath-1H vs. Our Standard Center Treatment Protocol in Living Donor Renal Transplantation - A Study to Evaluate the Avoidance of Long-term Nephrotoxic Calcineurin Inhibitor Therapy
Conditions
Interventions
Anti-Thymocyte Globulin vs Campath-1H vs Daclizumab
Locations
1
United States
University of Miami Jackson Memorial Hospital
Miami, Florida, United States
Start Date
November 1, 2005
Primary Completion Date
April 1, 2007
Completion Date
December 1, 2008
Last Updated
January 12, 2010
NCT04634916
NCT07396753
NCT06933472
NCT07224763
NCT07033260
NCT05738525
Lead Sponsor
University of Miami
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions